Joshua T. Brumm, CEO & President at Dyne Therapeutics, Inc. (DYN), sold 174,090 shares at $29.23 ($5.1M) on 2024-03-01, disclosed to the SEC on 2024-03-01.
Scheduled sale ($5.1M) by CEO & President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.50 | 5,520 | $152K | 3.0% |
| 2 | $28.25 | 18,976 | $536K | 10.6% |
| 3 | $29.23 | 74,090 | $2.2M | 42.8% |
| 4 | $29.23 | 74,090 | $2.2M | 42.8% |
| 5 | $29.70 | 1,414 | $42K | 0.8% |
| Total | $29.07 avg | 174,090 |
| $5.1M |
| 100% |
| Filing → |
| DYN | SELL | 2024-03-12 | $22.2M | — | Filing → |
| DYN | SELL | 2024-03-11 | $470K | — | Filing → |
| DYN | SELL | 2024-01-04 | $9.7M | — | Filing → |